These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6777285)

  • 1. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M
    Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M
    J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
    Zakarija M; Jin S; McKenzie JM
    J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
    Knight J; Laing P; Knight A; Adams D; Ling N
    J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.
    Kouki T; Inui T; Hachiya T; Okabe H; Ochi Y; Kajita Y
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):183-8. PubMed ID: 9135700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
    Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
    Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating antibody (TSAb) of Graves' disease.
    Zakarija M; McKenzie JM
    Life Sci; 1983 Jan 3-10; 32(1-2):31-44. PubMed ID: 6131365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
    Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
    Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses.
    Weetman AP; Yateman ME; Ealey PA; Black CM; Reimer CB; Williams RC; Shine B; Marshall NJ
    J Clin Invest; 1990 Sep; 86(3):723-7. PubMed ID: 2168443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
    Ochi Y; Kajita Y; Hachiya T; Hamaoki M
    Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
    Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    Akamizu T; Matsuda F; Okuda J; Li H; Kanda H; Watanabe T; Honjo T; Mori T
    J Immunol; 1996 Oct; 157(7):3148-52. PubMed ID: 8816426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M; McKenzie JM; Munro DS
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
    Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
    J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.